Posts Tagged ‘ 510(k) ’

PBS “Need to Know” Friday, March 22 on FDA and Medical, Surgical Devices

Mar 22nd, 2013 | By
PBS “Need to Know”  Friday, March 22 on FDA and Medical, Surgical Devices

March 22, 2013 ~ Friday night, March 22, Public Broadcasting (PBS) looks into the U.S. Food and Drug Administration (FDA) oversight of medical devices and how so many enter the market with little review and oversight. The 510(k) process allows devices on the market after the manufacturer requests clearance from the FDA and names a
[continue reading...]



$8.3 Million Verdict Against J&J’s DePuy Unit Over ASR Metal Hip

Mar 8th, 2013 | By

March 8, 2013 ~ Johnson & Johnson must pay the plaintiff who brought the first DePuy metal hip implant device to trial $8.3 million in damages, a Los Angeles jury decided this afternoon. This is the first of 10,750 product liability lawsuits against J&J’s DePuy unit which makes the ASR XL hip replacement device. The
[continue reading...]



Day 8: Linda Gross v Ethicon, Prolift Launched Under FDA Radar

Jan 22nd, 2013 | By
Day 8: Linda Gross v Ethicon, Prolift Launched Under FDA Radar

January 22, 2013 ~ Much thanks to Courtroom View Network for access to the live court proceedings and graphics shown to the jury. The Prolift surgical mesh did not undergo any FDA approval before it was marketed in March 2005. Last June Ethicon, a division of Johnson & Johnson announced it was removing Prolift and
[continue reading...]



Day Two Ethicon Trial: What J&J Knew About Transvaginal Mesh and When

Jan 13th, 2013 | By
Day Two Ethicon Trial: What J&J  Knew About Transvaginal Mesh and When

January 12~ 2012 Thanks to Courtroom View Network for providing a live feed to MDND. Day two of Linda Gross v Ethicon trial in an Atlantic City court brought an Ethicon engineer to the stand who was presented with a mountain of internal company documents intended to show how safety and efficacy of the Prolift
[continue reading...]



Most High-Risk Heart Devices Approved With No Tests

Nov 25th, 2012 | By
Most High-Risk Heart Devices Approved With No Tests

November 24, 2012 ~  Most readers of Mesh Medical Device News Desk are familiar with the ease with which surgical mesh and other medical devices make it to the market. An exchange of paperwork and a claim of ‘substantial equivalence’ to another device already being sold, and a manufacturer can launch his product- even a
[continue reading...]



FDA Whistleblower Case Moving Ahead

Nov 13th, 2012 | By
FDA Whistleblower Case Moving Ahead

November 13, 2012 ~Round one in the FDA whistleblower scandal goes to the U.S. Food and Drug Administration. Regulatory Focus (here) reports the FDA had a minor victory November 9, in its case against the National Whistleblower Center (NWC) which is representing five both current and former employees of the FDA who claim they were
[continue reading...]



Teresa Hughes: Demanding Answers and Raising the Profile of Vaginal Mesh Injuries in the UK

Nov 5th, 2012 | By
Teresa Hughes: Demanding Answers and Raising the Profile of Vaginal Mesh Injuries in the UK

Teresa Hughes, 61, a resident of Liverpool, England, and mother of two, has made so much noise about defective vaginal mesh that last year she was profiled in the UK paper, The Daily Mail. It started: “Thousands of women have been left severely damaged as a result of an implantable ‘sling’ operation to treat problems
[continue reading...]



FDA Follows Industry Lead to Shorten Time to Market

Oct 31st, 2012 | By
FDA Follows Industry Lead to Shorten Time to Market

October 30, 2012 ~    The FDA has issued the new rules for medical device makers to speed up the time it takes for medical devices to make it to market. Earlier this year industry agreed to pay $595 million over 5 years to the FDA as part of its operating budget. In exchange, the
[continue reading...]



What Happened to the FDA Request for Transvaginal Mesh Studies?

Sep 19th, 2012 | By
What Happened to the FDA Request for Transvaginal Mesh Studies?

September 19, 2012 ~ Last January, after a five-fold increase in complications was noted by the U.S. Food and Drug Administration (FDA) concerning synthetic mesh used in women to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI), the FDA ordered mesh makers to find out why. At the time, the unprecedented request was
[continue reading...]



FDA: How to Follow Medical Devices?

Sep 4th, 2012 | By
FDA: How to Follow Medical Devices?

Public Invited to FDA meeting on Postmarket Surveillance September 4, 2012~ Every modern day vehicle comes complete with a VIN number, an identifier number that stays with the car during its lifetime. If there is an auto recall the owner is notified and an auto dealership can easily identify a vehicle that might fall under
[continue reading...]



We hope you find this a helpful resource. National News Editor, Jane Akre, began MDND with the hope of providing the latest news, information and perspective from the regulatory, industry and patient point of view, something that goes under-reported in much of the coverage of medical devices. The public is just now becoming aware that many devices do not undergo the same scrutiny as prescription drugs and are instead grandfathered in under an FDA loophole that has gone largely unchanged since the 1970s. As a result, patients become the post-market clinical trial subjects, and many suffer devastating and permanent injuries.